AEYE Health

As 2024 comes to a close, we want to take a moment to reflect on an incredible year of connection and collaboration. Thank you to everyone who met with us at key industry events, including American Diabetes Association's 84th Scientific Sessions, American Academy of Family Physicians's FMX 2024, California Primary Care Association (CPCA) Conference, American Academy of Home Care Medicine Annual Meeting, American Academy of Ophthalmology (AAO) Annual Meeting, and HLTH Inc. 2024. Your enthusiasm and shared commitment to advancing diabetic eye care through innovative AI solutions inspire us every day. 🎥 Here’s a quick look back at some of our favorite moments from the year! Wishing you all a joyful holiday season and a happy, healthy New Year. We look forward to reconnecting in 2025 and continuing the conversation! 🌟 #AIDiagnostics #DiabeticRetinopathy #DiabetesManagement

🌟 Revolutionizing Diabetic Eye Care: AEYE Health and UMass Memorial Health Lead the Way AEYE Health and UMass Memorial Health (UMMH) proudly announced the integration of AEYE-DS, an AI-powered autonomous diagnostic screening solution, into UMMH’s EMR system. This transformative innovation has brought diabetic retinopathy screening to primary care, boosting adherence from 29% to 49% in just four months and reducing screening time by taking only one to two minutes on average. With real-time diagnoses, streamlined workflows, and CPT 92229 reimbursement, this collaboration is driving significant improvements in patient outcomes and quality metrics. This collaboration is dedicated to the late Dr. James Ledwith, whose visionary leadership made this milestone possible. Dr. Ledwith's contributions to diabetic care have left a lasting impact, inspiring ongoing innovation and collaboration for better healthcare outcomes. Read the full press release to see how we’re shaping the future of diabetic eye care: https://lnkd.in/gheEfkGa #DiabeticRetinopathy #DiabeticEyeCare #Innovation #EMRIntegration

🎉 Excited to share that AEYE Health has been featured in TechRound’s article, "World Diabetes Day: The Startups Improving Diabetes Care"! We’re honored to be recognized among the innovative companies driving change in diabetes care. At AEYE Health, we’re dedicated to revolutionizing diabetic eye disease screening with our groundbreaking AI diagnostic solution. As the first and only FDA-cleared portable screening technology, it delivers a one-minute screening with an on-the-spot diagnosis—making screenings quick, easy, and accessible anywhere. This empowers early detection and better outcomes for patients. 🌟👁️🗨️ A big thank you to TechRound for highlighting our mission this World Diabetes Day. Together, we’re shaping a healthier future. 💙 Read the full article here: https://lnkd.in/gDNSR4GF #WorldDiabetesDay #AIDiagnostics #DiabetesCare #DiabeticRetinopathy

November marks Diabetic Eye Disease Awareness Month 🗓️ - a time to spotlight the silent yet serious risk of vision loss 👁️ faced by millions living with diabetes. With fewer than 50% of diabetic patients adhering to annual screenings 🩺, AI-driven solutions are bridging this gap, making exams more accessible, faster, and efficient for both patients and providers. This month, let’s raise awareness and support innovative solutions that bring essential eye care to those who need it most. 🌐💙 👉 Read more about how AI is transforming diabetic eye disease screening here: https://lnkd.in/gMjAie2y #DiabeticEyeDiseaseAwarenessMonth #AIinHealthcare #AIDiagnostics

We're honored! 🎉 AEYE Health has been recognized in Healthcare Digital's list of Top 10 Digital Diagnostic Platforms for our innovative AI-powered retinal screening solutions. Our AI-powered retinal screening solutions are transforming the early detection of eye diseases and systemic conditions, especially in primary care. With FDA clearance for the only practical, fully autonomous, portable solution for diabetic retinopathy screening, we’re making early detection more accessible, helping to prevent vision loss, and enhancing patient outcomes. A big thank you to our team, partners, and customers for being part of this journey! 🙌 Read more: https://lnkd.in/g2gA9hNT #AIinHealthcare #HealthTech #DiabetesCare #DiabeticRetinoapthy #PatientCare #AEYEHealth

💡AI-powered chronic disease management is revolutionizing primary care by making healthcare more personalized, efficient, and cost-effective. With the increasing prevalence of chronic conditions like diabetes, AI is playing a critical role in enhancing patient care, streamlining workflows, and improving outcomes. From real-time monitoring and personalized health insights to automating routine tasks and empowering patients to manage their health, AI is transforming how we approach chronic disease. 🌟 Read the article "AI-Powered Chronic Disease Management: A Game-Changer for Primary Care" to discover how AI is reshaping the landscape of chronic disease management and helping to reduce healthcare costs while improving care delivery. 🔍 👉 https://lnkd.in/gXEmDuut #AI #HealthcareInnovation #ChronicDiseaseManagement #PrimaryCare #HealthTech #PatientCare #AIinHealthcare

👀 Transform Your Practice with Effortless Diabetic Retinopathy Screening! Curious about how to make diabetic retinopathy screening faster, easier, and more accessible for your patients? AEYE-DS brings the power of AI directly into primary care, offering a one-minute, specialist-free exam that can be performed by any clinic staff member, without dilation. Plus, it integrates smoothly with EMRs, automates billing through CPT 92229, and maximizes reimbursements—all while boosting quality metrics and patient engagement. Ready to see how this solution can elevate your practice? 🌟 Read the full article to explore AEYE-DS’s impact on patient care and clinic efficiency! 👉https://lnkd.in/gf7nydjy #DiabeticRetinopathy #AIDiagnostics #CPT92229 #DiabeticEyeExam

🌟 October Highlights: Celebrating Connections and Innovations! 🌟 This month, we had the pleasure of connecting with so many of you at major conferences, where we showcased Aurora AEYE—the first and only FDA-cleared portable AI solution for diabetic eye exams. With quick, 1-minute exams that require no dilation, Aurora AEYE brings accessible and efficient screening to clinical settings and patients' homes, reimbursable under CPT 92229, bridging the diabetic eye exam care gap. A heartfelt thank you to everyone who joined us at: American Academy of Ophthalmology (AAO) Annual Meeting in Chicago- exploring AEYE-DS's impact on retinal screening and patient outcomes. California Primary Care Association (CPCA) Conference in Sacramento and the American Academy of Home Care Medicine (AAHCM) Annual Meeting in Phoenix, where, alongside Optomed US, presenting Aurora AEYE for in-clinic and in-home use. HLTH Inc. in Las Vegas, introducing attendees to our 1-minute, on-the-spot screening solution that delivers instant results with no dilation required! We would love to continue the conversation with all of you and explore how we can work together to advance diabetic eye care. Thank you for your support and enthusiasm! Here’s to making a difference together! 👁️✨ #AAO2024 #CPCA24AC #AAHCM2024 #HLTHUSA #HLTH2024 #AIinHealthcare #RetinalScreening #Ophthalmology #AEYEHealth #DiabeticRetinopathy

🌟 Only two days left at the HLTH Inc. conference! We had an incredible first day connecting with healthcare professionals, and we're excited for what's to come! If you're attending, don't miss the chance to visit us at booth #2254 (kiosk 7) and experience Aurora AEYE, the first and only FDA-cleared portable AI solution for diabetic eye exams! Our groundbreaking technology offers 1-minute, on-the-spot screenings with instant results—all without dilation. It’s designed for seamless integration into both clinical and home care settings, making it easier than ever to close the diabetic eye exam care gap and improve patient outcomes. Plus, it's reimbursable under CPT 92229! 📅 Book a demo here: https://lnkd.in/gDcBMU4b Don’t miss out on seeing how Aurora AEYE is revolutionizing diabetic eye care! 👁️💡 #HLTHUSA #HLTH2024 #AIHealthcare #DiabeticEyeCare #PortableAI #PatientOutcomes #DiabeticRetinopathy

🌟 Visit us tomorrow at HLTH Inc. to see the first FDA-cleared portable AI solution for diabetic eye exams at booth #2254 (kiosk 7)! Our revolutionary technology delivers 1-minute, on-the-spot screenings with instant results—no dilation required—at any point of care! Designed for seamless integration into both clinical and home care settings, Aurora AEYE enhances access to care, helps close the diabetic eye exam care gap, and boosts patient outcomes. Plus, it’s reimbursable under CPT 92229! 📅 Book a demo here: https://lnkd.in/gAzKMr58 Stop by to discover how we’re advancing diabetic eye care! 👁️💡 #HLTHUSA #HLTH2024 #AIHealthcare #DiabeticEyeCare #PortableAI #PatientOutcomes